AAPL   321.94 (+1.20%)
MSFT   183.04 (+0.68%)
FB   230.29 (+0.50%)
GOOGL   1,433.70 (+0.94%)
AMZN   2,421.52 (+0.46%)
NVDA   346.41 (+1.58%)
CGC   20.91 (+5.08%)
MU   47.99 (-2.95%)
TSLA   816.88 (-0.41%)
AMD   53.39 (+1.23%)
T   31.43 (-1.35%)
ACB   16.28 (+6.41%)
F   5.94 (-1.49%)
DIS   118.46 (-2.53%)
BAC   25.23 (-2.89%)
BA   153.27 (+2.51%)
AAPL   321.94 (+1.20%)
MSFT   183.04 (+0.68%)
FB   230.29 (+0.50%)
GOOGL   1,433.70 (+0.94%)
AMZN   2,421.52 (+0.46%)
NVDA   346.41 (+1.58%)
CGC   20.91 (+5.08%)
MU   47.99 (-2.95%)
TSLA   816.88 (-0.41%)
AMD   53.39 (+1.23%)
T   31.43 (-1.35%)
ACB   16.28 (+6.41%)
F   5.94 (-1.49%)
DIS   118.46 (-2.53%)
BAC   25.23 (-2.89%)
BA   153.27 (+2.51%)
AAPL   321.94 (+1.20%)
MSFT   183.04 (+0.68%)
FB   230.29 (+0.50%)
GOOGL   1,433.70 (+0.94%)
AMZN   2,421.52 (+0.46%)
NVDA   346.41 (+1.58%)
CGC   20.91 (+5.08%)
MU   47.99 (-2.95%)
TSLA   816.88 (-0.41%)
AMD   53.39 (+1.23%)
T   31.43 (-1.35%)
ACB   16.28 (+6.41%)
F   5.94 (-1.49%)
DIS   118.46 (-2.53%)
BAC   25.23 (-2.89%)
BA   153.27 (+2.51%)
AAPL   321.94 (+1.20%)
MSFT   183.04 (+0.68%)
FB   230.29 (+0.50%)
GOOGL   1,433.70 (+0.94%)
AMZN   2,421.52 (+0.46%)
NVDA   346.41 (+1.58%)
CGC   20.91 (+5.08%)
MU   47.99 (-2.95%)
TSLA   816.88 (-0.41%)
AMD   53.39 (+1.23%)
T   31.43 (-1.35%)
ACB   16.28 (+6.41%)
F   5.94 (-1.49%)
DIS   118.46 (-2.53%)
BAC   25.23 (-2.89%)
BA   153.27 (+2.51%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Theravance BiopharmaBELLUS HealthInsmedEpizymeTurning Point Therapeutics
SymbolNASDAQ:TBPHOTCMKTS:BLUSFNASDAQ:INSMNASDAQ:EPZMNASDAQ:TPTX
Price Information
Current Price$25.40N/A$25.44$19.03$68.78
52 Week RangeBuyN/ABuyBuyBuy
Beat the Market™ Rank
Overall Score1.50.51.31.61.1
Analysis Score3.40.03.53.41.5
Community Score2.42.52.52.82.9
Dividend Score0.00.00.00.00.0
Ownership Score1.00.00.01.01.0
Earnings & Valuation Score0.60.00.60.60.0
Analyst Ratings
Consensus RecommendationBuyN/ABuyBuyBuy
Consensus Price Target$37.00N/A$42.00$30.71$69.00
% Upside from Price Target45.67% upsideN/A65.09% upside61.40% upside0.32% upside
Trade Information
Market Cap$1.68 billion$1.52 billion$2.64 billion$1.90 billion$2.29 billion
Beta1.541.552.752.06N/A
Average Volume235,46661,9331,420,550690,900552,371
Sales & Book Value
Annual Revenue$73.41 million$30,000.00$136.47 million$23.80 millionN/A
Price / Sales21.830.0018.8480.81N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value($2.50) per share$0.25 per share$2.05 per share$3.01 per share$10.63 per share
Price / Book-10.160.0012.416.32N/A
Profitability
Net Income$-236,460,000.00$-7,010,000.00$-254,340,000.00$-170,290,000.00$-72,130,000.00
EPS($4.25)N/A($3.01)($1.93)($2.99)
Trailing P/E RatioN/A0.00N/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-280.80%-49,910.34%-162.82%-1,111.58%N/A
Return on Equity (ROE)N/A-48.37%-87.35%-67.19%-32.81%
Return on Assets (ROA)-47.43%-45.25%-33.04%-48.52%-31.55%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A1.74%0.22%0.01%
Current Ratio5.45%13.87%6.89%14.81%34.91%
Quick Ratio5.45%13.87%6.46%14.74%34.91%
Ownership Information
Institutional Ownership Percentage88.47%N/AN/A90.43%81.58%
Insider Ownership Percentage5.90%24.17%4.63%16.30%23.20%
Miscellaneous
Employees3631037312450
Shares Outstanding63.09 million159.12 million101.04 million101.06 million35.92 million
Next Earnings Date7/29/2020 (Estimated)N/A8/6/2020 (Estimated)8/14/2020 (Estimated)8/4/2020 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.